Exact Mass: 507.2005404
Exact Mass Matches: 507.2005404
Found 162 metabolites which its exact mass value is equals to given mass value 507.2005404
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tyr-Tyr-Tyr
Cys Glu Glu Lys
C19H33N5O9S (507.19988880000005)
Cys Glu Lys Glu
C19H33N5O9S (507.19988880000005)
Cys Lys Glu Glu
C19H33N5O9S (507.19988880000005)
Asp Asp Lys Met
C19H33N5O9S (507.19988880000005)
Asp Asp Met Lys
C19H33N5O9S (507.19988880000005)
Asp Lys Asp Met
C19H33N5O9S (507.19988880000005)
Asp Lys Met Asp
C19H33N5O9S (507.19988880000005)
Asp Met Asp Lys
C19H33N5O9S (507.19988880000005)
Asp Met Lys Asp
C19H33N5O9S (507.19988880000005)
Asp Asn Pro Tyr
C22H29N5O9 (507.19651840000006)
Asp Asn Tyr Pro
C22H29N5O9 (507.19651840000006)
Asp Pro Asn Tyr
C22H29N5O9 (507.19651840000006)
Asp Pro Tyr Asn
C22H29N5O9 (507.19651840000006)
Asp Ser Thr Trp
C22H29N5O9 (507.19651840000006)
Asp Ser Trp Thr
C22H29N5O9 (507.19651840000006)
Asp Thr Ser Trp
C22H29N5O9 (507.19651840000006)
Asp Thr Trp Ser
C22H29N5O9 (507.19651840000006)
Asp Trp Ser Thr
C22H29N5O9 (507.19651840000006)
Asp Trp Thr Ser
C22H29N5O9 (507.19651840000006)
Asp Tyr Asn Pro
C22H29N5O9 (507.19651840000006)
Asp Tyr Pro Asn
C22H29N5O9 (507.19651840000006)
Glu Cys Glu Lys
C19H33N5O9S (507.19988880000005)
Glu Cys Lys Glu
C19H33N5O9S (507.19988880000005)
Glu Glu Cys Lys
C19H33N5O9S (507.19988880000005)
Glu Glu Lys Cys
C19H33N5O9S (507.19988880000005)
Glu Lys Cys Glu
C19H33N5O9S (507.19988880000005)
Glu Lys Glu Cys
C19H33N5O9S (507.19988880000005)
Glu Met Gln Thr
C19H33N5O9S (507.19988880000005)
Glu Met Thr Gln
C19H33N5O9S (507.19988880000005)
Glu Gln Met Thr
C19H33N5O9S (507.19988880000005)
Glu Gln Thr Met
C19H33N5O9S (507.19988880000005)
Glu Ser Ser Trp
C22H29N5O9 (507.19651840000006)
Glu Ser Trp Ser
C22H29N5O9 (507.19651840000006)
Glu Thr Met Gln
C19H33N5O9S (507.19988880000005)
Glu Thr Gln Met
C19H33N5O9S (507.19988880000005)
Glu Trp Ser Ser
C22H29N5O9 (507.19651840000006)
Phe Asn Asn Asn
Lys Cys Glu Glu
C19H33N5O9S (507.19988880000005)
Lys Asp Asp Met
C19H33N5O9S (507.19988880000005)
Lys Asp Met Asp
C19H33N5O9S (507.19988880000005)
Lys Glu Cys Glu
C19H33N5O9S (507.19988880000005)
Lys Glu Glu Cys
C19H33N5O9S (507.19988880000005)
Lys Met Asp Asp
C19H33N5O9S (507.19988880000005)
Met Asp Asp Lys
C19H33N5O9S (507.19988880000005)
Met Asp Lys Asp
C19H33N5O9S (507.19988880000005)
Met Glu Gln Thr
C19H33N5O9S (507.19988880000005)
Met Glu Thr Gln
C19H33N5O9S (507.19988880000005)
Met Lys Asp Asp
C19H33N5O9S (507.19988880000005)
Met Gln Glu Thr
C19H33N5O9S (507.19988880000005)
Met Gln Thr Glu
C19H33N5O9S (507.19988880000005)
Met Thr Glu Gln
C19H33N5O9S (507.19988880000005)
Met Thr Gln Glu
C19H33N5O9S (507.19988880000005)
Asn Asp Pro Tyr
C22H29N5O9 (507.19651840000006)
Asn Asp Tyr Pro
C22H29N5O9 (507.19651840000006)
Asn Phe Asn Asn
Asn Asn Phe Asn
Asn Asn Asn Phe
Asn Pro Asp Tyr
C22H29N5O9 (507.19651840000006)
Asn Pro Tyr Asp
C22H29N5O9 (507.19651840000006)
Asn Tyr Asp Pro
C22H29N5O9 (507.19651840000006)
Asn Tyr Pro Asp
C22H29N5O9 (507.19651840000006)
Pro Asp Asn Tyr
C22H29N5O9 (507.19651840000006)
Pro Asp Tyr Asn
C22H29N5O9 (507.19651840000006)
Pro Asn Asp Tyr
C22H29N5O9 (507.19651840000006)
Pro Asn Tyr Asp
C22H29N5O9 (507.19651840000006)
Pro Tyr Asp Asn
C22H29N5O9 (507.19651840000006)
Pro Tyr Asn Asp
C22H29N5O9 (507.19651840000006)
Gln Glu Met Thr
C19H33N5O9S (507.19988880000005)
Gln Glu Thr Met
C19H33N5O9S (507.19988880000005)
Gln Met Glu Thr
C19H33N5O9S (507.19988880000005)
Gln Met Thr Glu
C19H33N5O9S (507.19988880000005)
Gln Thr Glu Met
C19H33N5O9S (507.19988880000005)
Gln Thr Met Glu
C19H33N5O9S (507.19988880000005)
Ser Asp Thr Trp
C22H29N5O9 (507.19651840000006)
Ser Asp Trp Thr
C22H29N5O9 (507.19651840000006)
Ser Glu Ser Trp
C22H29N5O9 (507.19651840000006)
Ser Glu Trp Ser
C22H29N5O9 (507.19651840000006)
Ser Ser Glu Trp
C22H29N5O9 (507.19651840000006)
Ser Ser Trp Glu
C22H29N5O9 (507.19651840000006)
Ser Thr Asp Trp
C22H29N5O9 (507.19651840000006)
Ser Thr Trp Asp
C22H29N5O9 (507.19651840000006)
Ser Trp Asp Thr
C22H29N5O9 (507.19651840000006)
Ser Trp Glu Ser
C22H29N5O9 (507.19651840000006)
Ser Trp Ser Glu
C22H29N5O9 (507.19651840000006)
Ser Trp Thr Asp
C22H29N5O9 (507.19651840000006)
Thr Asp Ser Trp
C22H29N5O9 (507.19651840000006)
Thr Asp Trp Ser
C22H29N5O9 (507.19651840000006)
Thr Glu Met Gln
C19H33N5O9S (507.19988880000005)
Thr Glu Gln Met
C19H33N5O9S (507.19988880000005)
Thr Met Glu Gln
C19H33N5O9S (507.19988880000005)
Thr Met Gln Glu
C19H33N5O9S (507.19988880000005)
Thr Gln Glu Met
C19H33N5O9S (507.19988880000005)
Thr Gln Met Glu
C19H33N5O9S (507.19988880000005)
Thr Ser Asp Trp
C22H29N5O9 (507.19651840000006)
Thr Ser Trp Asp
C22H29N5O9 (507.19651840000006)
Thr Trp Asp Ser
C22H29N5O9 (507.19651840000006)
Thr Trp Ser Asp
C22H29N5O9 (507.19651840000006)
Trp Asp Ser Thr
C22H29N5O9 (507.19651840000006)
Trp Asp Thr Ser
C22H29N5O9 (507.19651840000006)
Trp Glu Ser Ser
C22H29N5O9 (507.19651840000006)
Trp Ser Asp Thr
C22H29N5O9 (507.19651840000006)
Trp Ser Glu Ser
C22H29N5O9 (507.19651840000006)
Trp Ser Ser Glu
C22H29N5O9 (507.19651840000006)
Trp Ser Thr Asp
C22H29N5O9 (507.19651840000006)
Trp Thr Asp Ser
C22H29N5O9 (507.19651840000006)
Trp Thr Ser Asp
C22H29N5O9 (507.19651840000006)
Tyr Asp Asn Pro
C22H29N5O9 (507.19651840000006)
Tyr Asp Pro Asn
C22H29N5O9 (507.19651840000006)
Tyr Asn Asp Pro
C22H29N5O9 (507.19651840000006)
Tyr Asn Pro Asp
C22H29N5O9 (507.19651840000006)
Tyr Pro Asp Asn
C22H29N5O9 (507.19651840000006)
Tyr Pro Asn Asp
C22H29N5O9 (507.19651840000006)
N-(4(4-PIPERIDINOMETHYL) PYRIDYL-2-OXY)-CIS-2-BUTENE)PHTALMIDE MALEATE
Fmoc-Nalpha-methyl-O-benzyl-L-tyrosine
C32H29NO5 (507.20456240000004)
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
C28H30ClN3O4 (507.19247300000006)
fmoc-glycine polymer-bound on wang
C32H29NO5 (507.20456240000004)
EMA401
C32H29NO5 (507.20456240000004)
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons[1][2][3][4].
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
SRT 1460
C26H29N5O4S (507.19401540000007)
SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues[1].
2-[[[2-Amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
C26H29N5O4S (507.19401540000007)
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)-4-acetyl-piperazine
C26H29N5O4S (507.19401540000007)
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
C20H33N3O12 (507.20641380000006)
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6R)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
C20H33N3O12 (507.20641380000006)
(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C26H35Cl2N3O3 (507.20553400000006)
(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C26H35Cl2N3O3 (507.20553400000006)
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C26H35Cl2N3O3 (507.20553400000006)
(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C26H35Cl2N3O3 (507.20553400000006)
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C26H35Cl2N3O3 (507.20553400000006)
NTNCB (hydrochloride)
C25H34ClN3O4S (507.1958434000001)
NTNCB (Compound 11) hydrochloride is a potent and selective neuropeptide Y Y5 (NPY Y5) receptor antagonist with a Ki of 8 nM against human Y5[1].
(1r,2r,4s,6s,7s,9s,10s,11s,12r,13s,14r)-2,4,6,9,11,13,14-heptahydroxy-11-isopropyl-7,10-dimethyl-3-methylidene-15-oxapentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan-12-yl 1h-pyrrole-2-carboxylate
(1'r,2s,2'r,6's,7's,9's,10's,11's,12'r,13's,14'r)-2',6',9',11',13',14'-hexahydroxy-11'-isopropyl-7',10'-dimethyl-15'-oxaspiro[oxirane-2,3'-pentacyclo[7.5.1.0¹,⁶.0⁷,¹³.0¹⁰,¹⁴]pentadecan]-12'-yl 1h-pyrrole-2-carboxylate
(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN001300","Ingredient_name": "(13s)-8,9-dehydro-18-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4930","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
20-norspiganthine-5-carboxylicacid
{"Ingredient_id": "HBIN003424","Ingredient_name": "20-norspiganthine-5-carboxylicacid","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC1CCC2(C3(CC4(C5(C(C3C(C5(C(C)C)O)OC(=O)C6=CC=CN6)(C2(C1O)O4)O)C)O)C(=O)O)O","Ingredient_weight": "507.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15785","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101131109","DrugBank_id": "NA"}
6-deoxy-6β,9β-epoxy-8α-hydroxy-10-epi-ryano-dine
{"Ingredient_id": "HBIN012313","Ingredient_name": "6-deoxy-6\u03b2,9\u03b2-epoxy-8\u03b1-hydroxy-10-epi-ryano-dine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5168","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-20-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013585","Ingredient_name": "8,9-dehydro-20-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4931","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,9-dehydro-21-hydroxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013586","Ingredient_name": "8,9-dehydro-21-hydroxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4932","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8α,9α-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013613","Ingredient_name": "8\u03b1,9\u03b1-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC6C(C5O)(O6)C)O)O4)O)C)O)C)O)OC(=O)C7=CC=CN7)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7090","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8β,9β-epoxy-10-epi-ryanodine
{"Ingredient_id": "HBIN013655","Ingredient_name": "8\u03b2,9\u03b2-epoxy-10-epi-ryanodine","Alias": "NA","Ingredient_formula": "C25H33NO10","Ingredient_Smile": "CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CC(C(=C)C5O)O)O)O4)O)C)O)C)O)OC(=O)C6=CC=CN6)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7091","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}